Market revenue in 2023 | USD 4,233.6 million |
Market revenue in 2030 | USD 7,446.3 million |
Growth rate | 8.4% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-house, Outsourcing |
Key market players worldwide | Genpact Ltd, Criterium Inc., Icon PLC, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Labcorp Holdings Inc, FREYR Battery Inc, Pharmexon, Cambridge Design Partnership, Voisin Consulting Life Sciences, Accell, PAREXEL, Promedica International, PharmaLex, NDA Regulatory Service GmbH, QVigilance, BlueReg Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory affairs market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 58.13% in 2023. Horizon Databook has segmented the U.S. regulatory affairs market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. accounts for a major share of clinical trial applications across the globe with 33.0% of total clinical trial applications being filed within the country in the year 2014-2016. Along with branded and patented products, there is also a strong demand for cost-effective generic and biosimilar products in this region.
In addition, there is also a significant increase in the import of generic and biosimilar products from emerging countries, which is increasing the demand for regulatory service providers in the region.
Big biopharmaceutical and medical device companies are outsourcing part of their regulatory functions such as report writing & publishing and clinical trial application services to regulatory service providers, thereby contributing to the growth of Regulatory affairs market in the U.S.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. regulatory affairs market , including forecasts for subscribers. This country databook contains high-level insights into U.S. regulatory affairs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account